{"id":333,"date":"2017-08-04T17:46:20","date_gmt":"2017-08-04T15:46:20","guid":{"rendered":"https:\/\/www.pharmarte.com\/?p=333"},"modified":"2017-08-04T17:46:20","modified_gmt":"2017-08-04T15:46:20","slug":"dietary-chromium-supplementation-for-targeted-treatment-of-diabetes-patients-with-comorbid-depression-and-binge-eating","status":"publish","type":"post","link":"https:\/\/www.pharmarte.com\/en\/dietary-chromium-supplementation-for-targeted-treatment-of-diabetes-patients-with-comorbid-depression-and-binge-eating\/","title":{"rendered":"Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating."},"content":{"rendered":"<div id=\"container\" class=\"hfeed\">\n<div id=\"wrapper\" class=\"clearfix\">\n<div id=\"content\" class=\"grid col-620\">\n<div id=\"post-1657\" class=\"post-1657 post type-post status-publish format-standard hentry category-inotir\">\n<div class=\"post-meta\">Med Hypotheses. 2015 Jul;85(1):45-8.<\/div>\n<div class=\"post-entry\">\n<p>Brownley KA(1), Boettiger CA(2), Young L(3), Cefalu WT(4).<\/p>\n<p>Dietary chromium supplementation for the treatment of diabetes remains controversial. The prevailing view that chromium supplementation for glucose regulation is unjustified has been based upon prior studies showing mixed, modest-sized effects in patients with type 2 diabetes (T2DM). Based on chromium\u2019s potential to improve insulin, dopamine, and serotonin function, we hypothesize that chromium has a greater glucoregulatory effect in individuals who have concurrent disturbances in dopamine and serotonin function\u2013that is, complex patients with comorbid diabetes, depression, and binge eating. We propose, as suggested by the collective data to date, the need to go beyond the \u201cone size fits all\u201d approach to chromium supplementation and put forth a series of experiments designed to link physiological and neurobehavioral processes in the chromium response phenotype.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Med Hypotheses. 2015 Jul;85(1):45-8. Brownley KA(1), Boettiger CA(2), Young L(3), Cefalu WT(4). Dietary chromium supplementation for the treatment of diabetes remains controversial. The prevailing view that<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-333","post","type-post","status-publish","format-standard","hentry","category-bibliografia-inotir"],"_links":{"self":[{"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/posts\/333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/comments?post=333"}],"version-history":[{"count":1,"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/posts\/333\/revisions"}],"predecessor-version":[{"id":334,"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/posts\/333\/revisions\/334"}],"wp:attachment":[{"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/media?parent=333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/categories?post=333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmarte.com\/en\/wp-json\/wp\/v2\/tags?post=333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}